0
November 3, 2009

Study author discusses ACP guideline on the benefit and risks of PED-5 Inhibitor Drugs for patients suffering from erectile dysfunction.

Running Time: (1:41)

Register for a FREE personal account

and access these and other features:

Want to Subscribe?
Learn More about subscription options.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)